Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 71 Neoplasms 64 Prostatic Neoplasms 45 Colorectal Neoplasms 41 Lung Neoplasms 37 Carcinoma, Non-Small-Cell Lung 26 Pancreatic Neoplasms 21 Neoplasm Metastasis 20 Hematologic Neoplasms 20 Head and Neck Neoplasms 19 Urinary Bladder Neoplasms 15 Ovarian Neoplasms 14 Multiple Myeloma 11 Motor Activity 11 Leukemia, Myeloid, Acute 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Glioblastoma 9 Colonic Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 8 Glioma 8 Gastrointestinal Neoplasms 8 Carcinoma, Renal Cell 8 COVID-19 8 Anxiety Disorders 8 Anatomic Stage I Breast Cancer AJCC v8 8 Rectal Neoplasms 7 Melanoma 7

Interventions

Insulin Glargine 4 Insulin 3 volagidemab 2 Metformin 2 Fulvestrant 2 Alpelisib 2 ziprasidone 1 relacorilant 1 pembrolizumab 1 exemestane 1 dapagliflozin 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Insulin Aspart 1 Injections 1 DNA, Ribosomal 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperglycemia × Standard of Care × Clear all

NCT05132244 2025-09-22

PEGASUS

British Columbia Cancer Agency

Phase NA Recruiting

Gastrointestinal

Hyperglycemia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡